Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Endoscopic Sedation
NCT03461718Phase 2Completed
- Sponsor
- Brooke Army Medical Center
- Start
- Mar 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ketamine in Procedural sedation (PS) (2 arms), sponsored by Brooke Army Medical Center. Primary endpoint: Patient Satisfaction with Sedation Instrument (PSSI) at 48 hours. Started Mar 2018; status: completed.
02
Drugs
ketamine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT03461718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461718.